II

103D CONGRESS

1ST SESSION S. 107

To mandate a study of the effectiveness of the National Drug Strategy

and to provide for an accounting of funds devoted to its implementation,

and for other purposes.

IN THE SENATE OF THE UNITED STATES

JANUARY 21 (legislative day, JANUARY 5), 1993

Mr. MOYNIHAN (for himself and Mr. CHAFEE) introduced the following bill;

which was read twice and referred to the Committee on Labor and

Human Resources

A BILL

To mandate a study of the effectiveness of the National

Drug Strategy and to provide for an accounting of funds

devoted to its implementation, and for other purposes.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. FINDINGS.

4 The Congress finds that—

5 (1) there is great disagreement concerning the

6 causes of the problem of epidemic drug addiction in

7 the United States and about the most effective way

8 to reduce it;
2

•S 107 IS

1 (2) one of the factors which most inhibits an ef2 fective response to the problem of epidemic drug ad3 diction in the United States is the lack of accurate

4 information concerning both the problem and the

5 specific effectiveness of each individual element of

6 the Nation’s antidrug effort;

7 (3) evaluating the effectiveness of the individual

8 elements of the Federal program to reduce epidemic

9 drug abuse requires accurately establishing cause

10 and effect relationship concerning drug addiction;

11 (4) the United States has promulgated a Na12 tional Drug Strategy pursuant to the requirements

13 of the 1988 Anti-Drug Abuse Act and will devote

14 many billions of dollars to antidrug programs for

15 many years to come; and

16 (5) it is in the interests of the Nation that

17 these funds be spent as effectively as possible and

18 that a permanent mechanism exist to audit their ex19 penditure.

20 SEC. 2. PURPOSES.

21 The purposes of this Act are to—

22 (1) require a study of the effectiveness of feder23 ally funded antidrug programs; and

24 (2) create a permanent auditing mechanism for

25 federally funded antidrug programs.
3

•S 107 IS

1 SEC. 3. STUDY OF ANTI-DRUG PROGRAMS.

2 (a) IN GENERAL.—The Secretary of Health and

3 Human Services (referred to in this Act as the ‘‘Sec4 retary’’) shall enter into appropriate arrangements with

5 the National Academy of Sciences to conduct a com6 prehensive study and investigation of the effectiveness in

7 reducing drug addiction of the various components of the

8 Federal antidrug program, including—

9 (1) crop eradication;

10 (2) crop substitution;

11 (3) support for foreign law enforcement;

12 (4) interdiction, including a separate analysis of

13 the effectiveness of the military services in the inter14 diction effort;

15 (5) education;

16 (6) treatment;

17 (7) support for local law enforcement;

18 (8) criminal justice system reforms; and

19 (9) research, including a separate analysis of ef20 fectiveness of pharmocological research and research

21 into other types of medical treatments for drug ad22 diction.

23 (b) METHODOLOGY.—The study described in sub24 section (a) shall to the maximum extent possible—
4

•S 107 IS

1 (1) study control for the effects of broad soci2 etal changes unrelated to specific antidrug initia3 tives, such as changing demographic patterns;

4 (2) separate the effects of such component of

5 the Federal antidrug program from the effects of

6 other antidrug initiatives;

7 (3) consider the extent to which the expenditure

8 of Federal funds on job training, education, and

9 other health, education, and welfare programs con10 tribute to reducing epidemic drug addiction;

11 (4) study the cost-effectiveness of each compo12 nent of the Federal antidrug program, as well as the

13 programs described in paragraph (3); and

14 (5) take into account the social and demo15 graphic factors which influence rates and forms of

16 epidemic drug addiction and provide, where possible,

17 information on the effectiveness of the various com18 ponents of the Federal antidrug program on various

19 demographic subgroups within the population.

20 (c) REPORTING.—In conducting the study described

21 in subsection (a), the National Academy of Sciences shall

22 provide to the Secretary and the Congress—

23 (1) not later than 6 months after the date of

24 enactment of this Act a detailed written description
5

•S 107 IS

1 of the manner in which the study will be conducted,

2 including a specific set of goals for the study;

3 (2) not later than 18 months after the date of

4 enactment of this Act the preliminary results of the

5 study; and

6 (3) not later than 2 years after the date of en7 actment of this Act the final results of the study.

8 (d) UPDATE OF STUDY.—The Secretary shall enter

9 into appropriate arrangements with the National Academy

10 of Sciences to update the results of the study described

11 in subsection (a) every 2 years following the initial report.

12 (e) ASSISTANCE FROM FEDERAL AGENCIES.—Agen13 cies of the Federal Government shall provide to the Na14 tional Academy of Sciences such information as it may

15 reasonably request for the purpose of conducting the study

16 described in subsection (a).

17 SEC. 4. AUDIT BY THE GOVERNMENT ACCOUNTING OFFICE.

18 (a) IN GENERAL.—The Government Accounting Of19 fice shall provide to the Congress on an annual basis an

20 audit report concerning the management and expenditures

21 of the component parts of the Federal antidrug program.

22 (b) SEPARATE COMPONENTS.—The report described

23 in (a) shall contain a separate section on each of the com24 ponent parts of the Federal antidrug program.
6

•S 107 IS

1 (c) ACCESS TO RECORDS.—In order to carry out the

2 purposes of this section, the Comptroller General shall

3 have such access to records, files, personnel, and facilities

4 of the Federal agencies involved in the Federal antidrug

5 program, including the military and intelligence services,

6 as the Comptroller General considers necessary.

Æ